PremiumThe FlyPnt Biopharma Global put volume heavy and directionally bearish Salesforce upgraded, Chipotle downgraded: Wall Street’s top analyst calls Point Biopharma downgraded to Hold from Buy at Brookline PremiumThe FlyLantheus, Point Biopharma report topline results from Phase 3 SPLASH trial Eli Lilly extends expiration of tender offer to acquire Point Biopharma Eli Lilly extends tender offer to acquire Point Biopharma PremiumThe FlyEli Lilly extends tender offer to acquire Point Biopharma for $12.50 per share PNT Earnings this Week: How Will it Perform? Point Biopharma downgraded to Neutral from Overweight at Piper Sandler 
